Kirk Bowden, DO
Pain Medicine · Mesa, AZNPI 1255592994
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (38.1%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 60 manufacturers reported payments, led by Medtronic at 37.7% of the total. Reporting peaked in 2020 at $14,391 and has fallen 87.0% since, to $1,868 in 2025. Among pain medicine clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 717 payments — averaging $71.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$19K
- Boston Scientific$9K
- Abbott$7K
- Tersera Therapeutics LLC$7K
- Spinal Simplicity, LLC$2K
- Vertiflex, Inc.$1K
- plus $6K from 54 others
What the payments were for
- Consulting fees$8,35216%
- Speaking & faculty fees$19,47038%
- Travel & lodging$7,41515%
- Food & beverage$14,52328%
- Education$1,3003%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RESTORE$6,593
- ADAPTIVESTIM$6,270
- PROCLAIM$6,100
- PRIALT$5,927
- SPECTRA WAVEWRITER$4,632
- INTELLIS ADAPTIVESTIM$2,867
- HA MINUTEMAN G3-R$1,587
- SYNCHROMEDII$1,429
- Superion ISS$1,244
- GENERAL - THERAPIES$907
- Intracept$646
- INTELLIS$230
- Proclaim IPG$163
- Omnia$161
- Senza Spinal Cord Stimulation System$149
- KYPHON Balloon Kyphoplasty$115
- mild Device Kit$108
- GENERAL PAIN MANAGEMENT$104
How this compares
$51,059 in reported general payments places this provider in the 90th percentile of 180 pain medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 14 | $16,043 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 11 | $3,688 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 131 | $3,154 |
| Buprenorphine | 11 | $2,993 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 178 | $2,598 |
| Oxycodone Hcl | 135 | $2,461 |
| Gabapentin | 102 | $1,944 |
| Pregabalin | 61 | $1,310 |
| Celecoxib | 62 | $1,183 |
| Morphine Sulfate ErMorphine Sulfate | 45 | $865 |
| Tramadol Hcl | 137 | $826 |
| Fentanyl | 11 | $739 |
| Hydromorphone Hcl | 31 | $562 |
| Tizanidine Hcl | 48 | $411 |
| Methocarbamol | 28 | $385 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $466 | $16,04314 claims |
| Hikma Pharmaceuticals USABuprenorphine-Naloxone, Buprenorphine | $19 | $6,68122 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 180 pain medicine providers in Arizona.
Other pain medicine in Mesa
- Zeeshan MalikMesa$14K
- Eric CornidezTucson$496K
- Tory McJunkinScottsdale$204K
- Minesh ZaveriPhoenix$187K
- Chad PletnickOro Valley$137K
- Tristan PicoChandler$121K
- Selaiman NooriLake Havasu City$104K
- Christine HaddadPhoenix$98K
- Samir PatelOro Valley$70K
- Vivek IyerScottsdale$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.